BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 2990692)

  • 1. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS in Haitian-Americans: a reassessment.
    Frank E; Weiss SH; Compas JC; Bienstock J; Weber J; Bodner A; Landesman SH
    Cancer Res; 1985 Sep; 45(9 Suppl):4619s-4620s. PubMed ID: 2990695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of human lymphotrophic retroviruses: an overview.
    Blattner WA; Biggar RJ; Weiss SH; Clark JW; Goedert JJ
    Cancer Res; 1985 Sep; 45(9 Suppl):4598s-4601s. PubMed ID: 2990691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of AIDS: current status and future prospects.
    Curran JW; Morgan WM; Hardy AM; Jaffe HW; Darrow WW; Dowdle WR
    Science; 1985 Sep; 229(4720):1352-7. PubMed ID: 2994217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III exposure among drug users.
    Ginzburg HM; Weiss SH; MacDonald MG; Hubbard RL
    Cancer Res; 1985 Sep; 45(9 Suppl):4605s-4608s. PubMed ID: 2861894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key epidemiologic questions about AIDS and infection with HTLV-III/LAV.
    Hopkins DR
    Public Health Rep; 1986; 101(3):234-7. PubMed ID: 3012620
    [No Abstract]   [Full Text] [Related]  

  • 13. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS: what is now known. I. History and immunovirology.
    Selwyn PA
    Hosp Pract (Off Ed); 1986 May; 21(5):67-76, 81-2. PubMed ID: 3009507
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
    Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
    N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired immunodeficiency syndrome (AIDS): present and future].
    Zanetti AR; Tanzi E; Zehender G; Cargnel A; Ferroni P
    Riv Emoter Immunoematol; 1986; 33(1):1-26. PubMed ID: 3532287
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical spectrum of HTLV-III in humans.
    Groopman JE
    Cancer Res; 1985 Sep; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.